HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
Status:
Not yet recruiting
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
This study is a clinical trial to assess the efficacy and confirm the safety of intratumoral
inoculation of G207 (an experimental virus therapy) combined with a single 5 Gy dose of
radiation in recurrent/progressive pediatric high-grade gliomas